Search for: "Astrazeneca" Results 181 - 200 of 1,244
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
23 Dec 2020, 8:05 am by Regan Zambri Long
AstraZeneca’s approach involves a vector vaccine, which carries the spike protein with help from the common cold virus. [read post]
22 Dec 2020, 8:05 am by Regan Zambri Long
The AstraZeneca vaccine won’t enter the picture in the U.S. until 2021. [read post]
15 Dec 2020, 12:15 pm by Rainer Winters
  Whistleblower revelations exposed corruption, insider trading and other violations from these European companies: Belgium: Anheuser-Busch  Estonia: Tallinex France: Société General, Sanofi, Total Italy: ENI  Netherlands: VimpelCom, Royal Dutch Shell, Koninklijke Philips Electronics Norway: Statoil  Poland: Biomet Russia: JSC VTB Banks, Mobile TeleSystems  Sweden: Telia, Ericsson Switzerland: Credit Suisse, Novartis  UK: GlaxoSmithKline, Barclays,… [read post]
12 Dec 2020, 11:39 am
The deal is the largest acquisition of a U.S. target company in 2020 and comes amid AstraZeneca's race to develop a COVID-19 vaccine. [read post]
11 Dec 2020, 12:58 pm by admin
By Bradford Williams Brad Williams Given pending anticipated FDA approval of Pfizer’s COVID-19 vaccine, and encouraging vaccine results from Moderna and AstraZeneca, many employers are wondering whether they may legally mandate vaccinations for their employees. [read post]
9 Dec 2020, 5:09 am by Brian Leiter
The Pfizer vaccine is very effective, the Oxford/AstraZeneca vaccine only moderately so. [read post]
7 Dec 2020, 9:03 pm by News Desk
Approval could come as early as Friday by the FDA Commissionerc Earlier the CDC advisory committee recommended the top priority for the first 24 million vaccines in the U.S. go to healthcare professionals and elderly residents of long-term care facilities Coming closely behind the Pfizer/BioNTech vaccine are two additional COVID-19 vaccinations, one by the biotech firm Moderna and the other from AstraZeneca, a pharmaceutical company. [read post]
3 Dec 2020, 8:03 pm by Sabrina I. Pacifici
Enthusiasm has surged in recent weeks as Moderna, Pfizer and AstraZeneca all announced initial results from Phase III trials in human patients that showed surprisingly powerful rates of immunity, with tests subjects given the drugs being 94% to 95% less likely than people given a placebo to contract COVID-19. [read post]
24 Nov 2020, 7:43 am by Tom Smith
With the recent reports by two vaccine makers (Pfizer and Moderna) of the results of their preliminary analysis of their Phase 3 trials showing greater than 90 percent protection—and now today’s announcement of a third, AstraZeneca’s, also boasting 90 percent effectiveness—there is cause for more optimism about the timeline for resuming life. [read post]
23 Nov 2020, 10:58 am by Anna Salvatore
AstraZeneca released preliminary data today showing that its vaccine is 70.4 percent effective on average between two dosing regimens. [read post]
23 Nov 2020, 6:12 am by Brian Leiter
Another two-dose vaccine, that was 90% effective in the group that got a half-dose first, and then a full dose second (but less effective in the group that got a full dose each time). [read post]
20 Nov 2020, 2:58 am
Some of this year's winners included AstraZeneca, Slaughter and May, Addleshaw Goddard, Cleary Gottlieb, Freeths and Paul Hastings. [read post]
Joining the majority of European courts, the Paris Court of Justice ruled that Eli Lilly’s patent, which relates to the combined administration of pemetrexed disodium and vitamin B12, was infringed by the marketing of Fresenius’ pemetrexed diacid. [read post]
16 Oct 2020, 12:28 pm by Anna Salvatore
Other late-stage vaccine trials by AstraZeneca and Johnson & Johnson are currently paused due to safety concerns. [read post]
16 Oct 2020, 11:17 am by IPWatchdog
This week in Other Barks & Bites: the Copyright Office issues a notice of proposed rulemaking on 17 proposed classes of use to be included in the eighth triennial round of exemptions to Section 1201 of the DMCA; the Federal Circuit partially reverses a Patent Trial and Appeal Board (PTAB) decision for erroneous claim construction and affirms a district court decision to abstain from a patent case due to a related state court proceeding; China’s national legislature considers long-term… [read post]
2 Oct 2020, 7:10 am by Lisa Larrimore Ouellette
Pfizer and Moderna published theirs on September 17, AstraZeneca followed suit on September 19, and Johnson & Johnson released theirs a few days later. [read post]
1 Oct 2020, 12:12 pm by John Jascob
AstraZeneca’s drug candidate, Tagrisso, hit required milestones using "confirmed" results. [read post]